Enochian BioSciences, Inc.: Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced

Related Keywords

Enochian Bioscience ,Mark Dybul ,Enochian Biosciences ,Enochian Biosciences Inc ,Hc Wainwright Global Life Sciences Conference , ,Global Life Sciences ,Fireside Chat ,Patrick Trucchio ,Managing Director ,Senior Healthcare Analyst ,Wednesday October ,Annual Report ,Enochian ,Iosciences ,Ireside ,Hat ,Park ,Ybul ,Wainwright ,Nnual ,Hepatitis ,Virus ,Conference ,